<code id='AF0A6CCBBE'></code><style id='AF0A6CCBBE'></style>
    • <acronym id='AF0A6CCBBE'></acronym>
      <center id='AF0A6CCBBE'><center id='AF0A6CCBBE'><tfoot id='AF0A6CCBBE'></tfoot></center><abbr id='AF0A6CCBBE'><dir id='AF0A6CCBBE'><tfoot id='AF0A6CCBBE'></tfoot><noframes id='AF0A6CCBBE'>

    • <optgroup id='AF0A6CCBBE'><strike id='AF0A6CCBBE'><sup id='AF0A6CCBBE'></sup></strike><code id='AF0A6CCBBE'></code></optgroup>
        1. <b id='AF0A6CCBBE'><label id='AF0A6CCBBE'><select id='AF0A6CCBBE'><dt id='AF0A6CCBBE'><span id='AF0A6CCBBE'></span></dt></select></label></b><u id='AF0A6CCBBE'></u>
          <i id='AF0A6CCBBE'><strike id='AF0A6CCBBE'><tt id='AF0A6CCBBE'><pre id='AF0A6CCBBE'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:79
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Takeaways from AdvaMed, the largest medical devices conference
          Takeaways from AdvaMed, the largest medical devices conference

          AttendeesattheAdvaMedConferenceinAnaheim,Calif.,onTuesday.EricThayerforSTATANAHEIM,Calif.—Thousandso

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Why Eli Lilly’s earnings didn’t quite live up to the hype

          KristofferTripplaar/APEventually,theluckiestcompaniesgettodealwithaveryparticularproblem:whattodowhe